OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 15 citing articles:

How macrophage heterogeneity affects tuberculosis disease and therapy
David G. Russell, Nelson V. Simwela, Joshua T. Mattila, et al.
Nature reviews. Immunology (2025)
Closed Access | Times Cited: 4

Osteopontin/SPP1: a potential mediator between immune cells and vascular calcification
Yanli Zhao, Zujuan Huang, Limei Gao, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 10

Inhibition of MERTK reduces organ fibrosis in mouse models of fibrotic disease
Ziyan Pan, Rasha El Sharkway, Ali Bayoumi, et al.
Science Translational Medicine (2024) Vol. 16, Iss. 741
Closed Access | Times Cited: 8

Regulation of macrophage activation by lactylation in lung disease
Yungeng Wei, Hua Guo, Shixing Chen, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 7

Methylglyoxal deteriorates macrophage efferocytosis in diabetic wounds through ROS-induced ubiquitination degradation of KLF4
Hanting Zhu, W. X. Wang, Jiajun Zhu, et al.
Free Radical Biology and Medicine (2025)
Closed Access

Innate immune checkpoint SIRPα/CD47 blockade ameliorates silica-induced pulmonary fibrosis by modulating macrophage immunity
Youliang Zhao, Meixiu Duan, Yuanmeng Qi, et al.
International Immunopharmacology (2025) Vol. 156, pp. 114723-114723
Closed Access

Trends and hotspots in pulmonary fibrosis biomarker research: a bibliometric analysis
Lingling Wang, Jianliang Huang, Gavin Tan, et al.
Frontiers in Medicine (2025) Vol. 12
Open Access

Recent advances in TAM mechanisms in lung diseases
Jia-Qi Ban, Jiayi Qian, Chi Zhang, et al.
Journal of Translational Medicine (2025) Vol. 23, Iss. 1
Open Access

Spatial and phenotypic heterogeneity of resident and monocyte-derived macrophages during inflammatory exacerbations leading to pulmonary fibrosis
Philip J. Moos, Jenna Cheminant, Sophie J. Cowman, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 2

Design, Synthesis, and Biological Evaluation of 2-Substituted Aniline Pyrimidine Derivatives as Potent Dual Mer/c-Met Inhibitors
Daowei Huang, Huiling Chen, Jixia Yang, et al.
Molecules (2024) Vol. 29, Iss. 2, pp. 475-475
Open Access | Times Cited: 1

Advances in common in vitro cellular models of pulmonary fibrosis
Die Li, Xinyue Zhang, Ziqiong Song, et al.
Immunology and Cell Biology (2024) Vol. 102, Iss. 7, pp. 557-569
Open Access | Times Cited: 1

Could Gas6/TAM Axis Provide Valuable Insights into the Pathogenesis of Systemic Sclerosis?
Daria Apostolo, Davide D’Onghia, Alessandra Nerviani, et al.
Current Issues in Molecular Biology (2024) Vol. 46, Iss. 7, pp. 7486-7504
Open Access | Times Cited: 1

Macrophage Dysfunction in Respiratory Disease
Shyreen Hassibi, Louise Donnelly
Results and problems in cell differentiation (2024), pp. 239-256
Closed Access

Optimized full-spectrum flow cytometry panel for deep immunophenotyping of murine lungs
Zora Baumann, Carsten Wiethe, Chiara Vecchi, et al.
Cell Reports Methods (2024), pp. 100885-100885
Open Access

The immune mechanisms of acute exacerbations of idiopathic pulmonary fibrosis
Tao Chen, Wei Sun, Zuojun Xu
Frontiers in Immunology (2024) Vol. 15
Open Access

Advances in common in vitro cellular models of pulmonary fibrosis
Die Li, Qian Weibin, Xinyue Zhang, et al.
Authorea (Authorea) (2023)
Open Access

Page 1

Scroll to top